Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cellectis S.A. - American Depositary Shares
(NQ:
CLLS
)
3.520
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 21, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cellectis S.A. - American Depositary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
October 07, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Wondering what's happening in today's pre-market session?
↗
September 29, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 29, 2025
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Via
Benzinga
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
September 29, 2025
U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Monday. Shares of Inventiva ADR (NASDAQ: IVA) fell sharply in today's pre-market trading following H1...
Via
Benzinga
Topics
Stocks
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
↗
September 29, 2025
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
September 19, 2025
Via
Benzinga
Top 5 Biotech Stocks With Strong Momentum
↗
August 28, 2025
Top 5 biotech stocks jumping into the top 10% momentum this week—ADCT, ARQT, CLLS, ENTO, HOTH—amid rapid sector rallies.
Via
Benzinga
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
August 04, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
↗
July 29, 2025
Via
Benzinga
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
July 28, 2025
From
Cellectis Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 25, 2025
Via
Benzinga
What's going on in today's session
↗
July 25, 2025
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
↗
July 14, 2025
Via
Benzinga
Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025
June 26, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
May 21, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Reports Financial Results for the First Quarter 2025
May 12, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Report First Quarter Financial Results on May 12, 2025
May 06, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Presents Non-Viral Gene Editing and Base Editing Innovation at the ASGCT Annual Meeting
April 28, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
April 22, 2025
Cellectis, backed by AstraZeneca funding and a multi-year cash runway, is advancing its prioritized allogeneic CAR-T pipeline toward pivotal 2025 milestones.
Via
MarketBeat
The market is filled with gapping stocks in Friday's session.
↗
April 11, 2025
Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Friday's After-Market Session
↗
March 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
March 14, 2025
Via
Benzinga
Why Rubrik Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
↗
March 14, 2025
Via
Benzinga
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
March 13, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 2025
March 07, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Earnings Scheduled For March 13, 2025
↗
March 13, 2025
Via
Benzinga
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
February 24, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)
December 10, 2024
From
Cellectis Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today